Literature DB >> 20102951

Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus.

David Aguilar1, Anita Deswal, Kumudha Ramasubbu, Douglas L Mann, Biykem Bozkurt.   

Abstract

Heart failure (HF) with preserved left ventricular ejection fraction (LVEF) and diabetes commonly coexist, but the impact of diabetes on HF outcomes in patients with HF and preserved LVEF has not been well studied. We assessed the risk of HF death or hospitalization for worsening HF associated with diabetes by studying 987 patients with HF and preserved LVEF enrolled in the Digitalis Investigation Group (DIG) ancillary study. Diabetics (n = 285, 28.9%) were younger, had a larger body mass index, faster heart rate, and higher pulse pressure than nondiabetics. Diabetics were also more likely to be women, have a history of hypertension, ischemic cause for HF, and were more likely to be treated with diuretics. During the mean follow-up of 37 months, 88 (30.9%) diabetics and 133 (19.0%) nondiabetics developed the primary outcome of HF hospitalization or HF death. After adjustments for baseline differences, diabetes was associated with a 68% increased risk of HF hospitalization or HF death (adjusted hazard ratio 1.68, 95% confidence interval 1.26 to 2.25, p <0.001). In conclusion, in patients with HF and preserved LVEF, diabetes is associated with significantly increased risk of developing adverse HF outcomes. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20102951      PMCID: PMC2813214          DOI: 10.1016/j.amjcard.2009.09.041

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

1.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

Authors:  Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

2.  The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study.

Authors:  J E Liu; V Palmieri; M J Roman; J N Bella; R Fabsitz; B V Howard; T K Welty; E T Lee; R B Devereux
Journal:  J Am Coll Cardiol       Date:  2001-06-01       Impact factor: 24.094

3.  Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?

Authors:  Kennedy Cruickshank; Lisa Riste; Simon G Anderson; John S Wright; Graham Dunn; Ray G Gosling
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

4.  Impact of diabetes mellitus on long-term survival in patients with congestive heart failure.

Authors:  Pascal De Groote; Nicolas Lamblin; Frédéric Mouquet; David Plichon; Eugène McFadden; Eric Van Belle; Christophe Bauters
Journal:  Eur Heart J       Date:  2004-04       Impact factor: 29.983

5.  Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations.

Authors:  Miho Kawaguchi; Ilan Hay; Barry Fetics; David A Kass
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

6.  Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug; Carolyn S P Lam; Véronique L Roger; Richard J Rodeheffer; Margaret M Redfield
Journal:  J Am Coll Cardiol       Date:  2009-07-28       Impact factor: 24.094

7.  Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus.

Authors:  Michaela Diamant; Hildo J Lamb; Ymte Groeneveld; Edwin L Endert; Jan W A Smit; Jeroen J Bax; Johannes A Romijn; Albert de Roos; Jasper K Radder
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

8.  Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

Authors:  Michael R MacDonald; Mark C Petrie; Fumi Varyani; Jan Ostergren; Eric L Michelson; James B Young; Scott D Solomon; Christopher B Granger; Karl Swedberg; Salim Yusuf; Marc A Pfeffer; John J V McMurray
Journal:  Eur Heart J       Date:  2008-04-14       Impact factor: 29.983

9.  Role of left ventricular stiffness in heart failure with normal ejection fraction.

Authors:  Dirk Westermann; Mario Kasner; Paul Steendijk; Frank Spillmann; Alexander Riad; Kerstin Weitmann; Wolfgang Hoffmann; Wolfgang Poller; Matthias Pauschinger; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Circulation       Date:  2008-04-14       Impact factor: 29.690

10.  Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle.

Authors:  Michael R Zile; Catalin F Baicu; William H Gaasch
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

View more
  25 in total

Review 1.  Heart failure in patients with type 2 diabetes mellitus: assessment with echocardiography and effects of antihyperglycemic treatments.

Authors:  Katsuomi Iwakura
Journal:  J Echocardiogr       Date:  2019-10-15

Review 2.  Diabetic cardiomyopathy: bench to bedside.

Authors:  Joel D Schilling; Douglas L Mann
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

3.  Weight and mortality following heart failure hospitalization among diabetic patients.

Authors:  Molly E Waring; Jane S Saczynski; David McManus; Michael Zacharias; Darleen Lessard; Joel M Gore; Robert J Goldberg
Journal:  Am J Med       Date:  2011-09       Impact factor: 4.965

4.  Diastolic function in patients with heart failure with preserved ejection fraction and atrial fibrillation: impact of diabetes.

Authors:  Ruxandra-Nicoleta Horodinschi; Camelia Cristina Diaconu
Journal:  Am J Cardiovasc Dis       Date:  2021-10-25

Review 5.  The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise.

Authors:  Joel D Schilling
Journal:  Antioxid Redox Signal       Date:  2015-04-15       Impact factor: 8.401

Review 6.  Heart Failure in Type 2 Diabetes Mellitus.

Authors:  Helena C Kenny; E Dale Abel
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

7.  Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.

Authors:  Brian R Lindman; Victor G Dávila-Román; Douglas L Mann; Steven McNulty; Marc J Semigran; Gregory D Lewis; Lisa de las Fuentes; Susan M Joseph; Justin Vader; Adrian F Hernandez; Margaret M Redfield
Journal:  J Am Coll Cardiol       Date:  2014-08-12       Impact factor: 24.094

8.  DPP-4 inhibitors, heart failure and type 2 diabetes: all eyes on safety.

Authors:  Francesco Paneni
Journal:  Cardiovasc Diagn Ther       Date:  2015-12

Review 9.  Consensus document: management of heart failure in type 2 diabetes mellitus.

Authors:  Upendra Kaul; Saumitra Ray; D Prabhakar; Arun Kochar; Kamal Sharma; Prakash Kumar Hazra; Subhash Chandra; Dharmesh Ramakant Bhai Solanki; Anjan Lal Dutta; Viveka Kumar; M Srinivas Rao; Abraham Oomman; Sameer Dani; Brian Pinto; T R Raghu
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

10.  Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).

Authors:  Stephan von Haehling; Mitja Lainscak; Wolfram Doehner; Piotr Ponikowski; Giuseppe Rosano; Jens Jordan; Piotr Rozentryt; Mathias Rauchhaus; Rostislav Karpov; Vsevolod Tkachuk; Yelena Parfyonova; Andrey Y Zaritskey; Eugeniy V Shlyakhto; John G Cleland; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.